Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001104659-20-095580

← back to feed
Filed
Aug 14, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Aug 14, 2020 20M sh
Shares Diluted Q1 2021 · Jun 30, 2020 20M sh
Shares Diluted Q1 2021 · Jun 30, 2019 20M sh
Operating Cash Flow Q1 2021 · Jun 30, 2020 $20.84K
Operating Cash Flow Q1 2021 · Jun 30, 2019 $24.6K
Cash And Equivalents Q1 2021 · Jun 30, 2020 $96.07K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $114.63K
Stockholders Equity Q1 2021 · Jun 30, 2020 $4.51M
Stockholders Equity Q1 2021 · Mar 31, 2020 $4.55M
Current Liabilities Q1 2021 · Jun 30, 2020 $2.86M
Current Liabilities Q1 2021 · Mar 31, 2020 $2.88M
Total Liabilities Q1 2021 · Jun 30, 2020 $2.87M
Total Liabilities Q1 2021 · Mar 31, 2020 $2.89M
Current Assets Q1 2021 · Jun 30, 2020 $657.25K
Current Assets Q1 2021 · Mar 31, 2020 $681.06K
Total Assets Q1 2021 · Jun 30, 2020 $7.46M
Total Assets Q1 2021 · Mar 31, 2020 $7.51M
Sga Expense Q1 2021 · Jun 30, 2020 $120.37K
Sga Expense Q1 2021 · Jun 30, 2019 $170.96K
Net Income Q1 2021 · Jun 30, 2020 $1.12K
Net Income Q1 2021 · Jun 30, 2019 −$191.15K
Operating Income Q1 2021 · Jun 30, 2020 $10.5K
Operating Income Q1 2021 · Jun 30, 2019 −$67.17K
Gross Profit Q1 2021 · Jun 30, 2020 $152.6K
Gross Profit Q1 2021 · Jun 30, 2019 $232.96K
Cost Of Revenue Q1 2021 · Jun 30, 2020 $66.53K
Cost Of Revenue Q1 2021 · Jun 30, 2019 $77.01K
Revenue Q1 2021 · Jun 30, 2020 $219.13K
Revenue Q1 2021 · Jun 30, 2019 $309.96K
Eps Diluted Q1 2021 · Jun 30, 2019 $0.00
Eps Basic Q1 2021 · Jun 30, 2019 $0.00